Literature DB >> 17472878

Growth factors in short-bowel syndrome patients.

Palle Bekker Jeppesen1.   

Abstract

Malabsorption is a key finding in patients with short-bowel syndrome. Malabsorption of nonessential and essential nutrients, fluids, and electrolytes, if not compensated for by increased intake, leads to diminished body stores and subclinical and (eventually) clinical deficiencies. After intestinal resection, adaptation (a spontaneous progressive recovery from the malabsorptive disorder) may be evident. This article describes selected factors responsible for the morphologic and functional changes in the adaptive processes and presents results of clinical trials that use either growth hormone or glucagon-like peptide-2 to facilitate a condition of hyperadaptation in short-bowel patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472878     DOI: 10.1016/j.gtc.2007.01.007

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  4 in total

1.  Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.

Authors:  Aaron P Garrison; Christopher M Dekaney; Douglas C von Allmen; P Kay Lund; Susan J Henning; Michael A Helmrath
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-31       Impact factor: 4.052

2.  Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.

Authors:  Palle Bekker Jeppesen
Journal:  Therap Adv Gastroenterol       Date:  2012-05       Impact factor: 4.409

3.  The Influence of Neocate in Paediatric Short Bowel Syndrome on PN Weaning.

Authors:  E De Greef; T Mahler; A Janssen; H Cuypers; G Veereman-Wauters
Journal:  J Nutr Metab       Date:  2010-05-31

4.  Endogenous growth hormone and insulin after interposition of a reversed jejunal segment in short bowel syndrome. An experimental study on pigs.

Authors:  Michail Papamichail; Michail Digalakis; Prigouris Panagiotis; Odysseas Paisios; Soyltana Loti; Theodoros Sergentanis
Journal:  BMC Res Notes       Date:  2012-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.